Gene expression in circulating tumor cells reveals a dynamic role of EMT and PD-L1 during osimertinib treatment in NSCLC patients

類似資料

• Detection of EGFR Mutations in Plasma cfDNA and Paired CTCs of NSCLC Patients before and after Osimertinib Therapy Using Crystal Digital PCR
  著者:: Ntzifa, Aliki, 等
  出版事項: (2021)
• Prognostic Significance of TWIST1, CD24, CD44, and ALDH1 Transcript Quantification in EpCAM-Positive Circulating Tumor Cells from Early Stage Breast Cancer Patients
  著者:: Strati, Areti, 等
  出版事項: (2019)
• Hypoxia-inducible factor-1α and vascular endothelial growth factor expression in circulating tumor cells of breast cancer patients
  著者:: Kallergi, Galatea, 等
  出版事項: (2009)
• Direct comparison study of DNA methylation markers in EpCAM-positive circulating tumour cells, corresponding circulating tumour DNA, and paired primary tumours in breast cancer
  著者:: Chimonidou, Maria, 等
  出版事項: (2017)
• CD8(+) PD-1(+) T-cells and PD-L1(+) circulating tumor cells in chemotherapy-naïve non-small cell lung cancer: towards their clinical relevance?
  著者:: Kotsakis, Athanasios, 等
  出版事項: (2019)